Moreover, we analyzed the association between the NR6A1/E‐cadherin/MAP2 expression (high or low) and clinicopathological parameters of TGCTs patients, and the results (Table S1) showed that high expression of NR6A1 and MAP2 was positively correlated with lymph node involvement (p < 0.05), and high E‐cadherin expression level was negatively correlated with lymph node involvement (p < 0.05), tumor size (p < 0.05) and metastasis (p < 0.05). The gene discussed is NR6A1; the disease is neoplasm.